Amarin Corporation (AMRN) financial statements

Healthcare · Drug Manufacturers - General · Market cap $245M

Amarin Corporation reported revenue of $214M in fiscal 2025, up 5.7% a year over 9 years.

Net income was -$39M and the operating margin -23.5%, against -50.4% in 2016.

The diluted share count rose 96% over the period (dilution).

Revenue and free cash flow

Fiscal years, $ billions.

-0.200.20.40.60.82016201720182019202020212022202320242025RevenueFree cash flow
Embed this chart

Free to use in articles and newsletters with the source line. Paste this HTML:

Income statement

Fiscal years, from Amarin Corporation's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Revenue$130M$181M$229M$430M$614M$583M$369M$307M$229M$214M
Cost of revenue$34M$45M$55M$96M$131M$121M————
Gross profit$96M$136M$175M$334M$483M$462M$242M$166M$81M$121M
Research and development$50M$47M$56M$34M$39M$29M$30M$22M$21M$20M
Selling, general and admin$111M$135M$227M$324M$463M$408M$304M$200M$152M$115M
Operating income-$66M-$46M-$108M-$24M-$20M$11M-$106M-$68M-$92M-$50M
Interest expense$19M$10M$9M$7M$3M$129,000$15,000$8,000$7,000$7,000
Pre-tax income-$76M-$55M-$116M-$22M-$17M$11M-$104M-$54M-$77M-$36M
Income tax$10M$13M$96,000$164,000$745,000$4M$2M$5M$5M$3M
Net income-$86M-$68M-$116M-$23M-$18M$8M-$106M-$59M-$82M-$39M
EPS (diluted)-$0.41-$0.25-$0.39-$0.07-$0.05$0.02-$0.26-$0.15-$0.20-$0.09
Diluted shares212M271M297M343M382M402M401M408M411M415M
Gross margin73.6%75.2%76.2%77.7%78.6%79.2%65.7%53.9%35.6%56.6%
Operating margin-50.4%-25.2%-47.2%-5.6%-3.2%1.8%-28.7%-22.0%-40.2%-23.5%
Net margin-66.4%-37.5%-50.8%-5.3%-2.9%1.3%-28.7%-19.3%-35.9%-18.2%

Balance sheet

Fiscal years, from Amarin Corporation's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Cash and short-term investments$98M$74M$249M$645M$501M$454M$309M$321M$294M$303M
Receivables$20M$45M$67M$116M$155M$164M$131M$134M$122M$127M
Inventory$21M$30M$58M$77M$189M$235M$229M$259M$166M$196M
Total current assets$146M$153M$378M$855M$879M$879M$689M$725M$595M$650M
Property, plant and equipment$78,000$28,000$63,000$2M$2M$1M$874,000$114,000$16,000$12,000
Total assets$167M$162M$386M$882M$966M$1.1B$886M$832M$685M$671M
Total current liabilities$76M$109M$157M$242M$307M$371M$259M$259M$180M$194M
Long-term debt$85M$71M$46M———————
Total liabilities$176M$227M$233M$274M$339M$401M$291M$280M$199M$211M
Shareholders' equity-$9M-$65M$152M$608M$628M$667M$595M$552M$486M$459M
Net debt$3M$20M-$169M-$594M-$187M-$219M-$218M-$199M-$121M-$135M

Cash flow

Fiscal years, from Amarin Corporation's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Operating cash flow-$72M-$33M-$95M-$9M-$22M-$67M-$180M$7M-$31M$7M
Capital spending$21,000$12,000$58,000$2M$252,000—————
Free cash flow-$72M-$33M-$95M-$12M-$22M—————
Stock-based compensation$14M$14M$19M$31M$46M$37M$26M$16M$18M$14M
Net borrowing—-$3M-$15M-$32M-$50M—————
Free cash flow margin-55.2%-18.1%-41.3%-2.8%-3.6%—————
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for AMRN.
Open AMRN in Investingly

Questions

What was Amarin Corporation's revenue in 2025?

$214M in fiscal 2025, from its 10-K filing.

From Amarin Corporation's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.